HTR1A and major depressive disorder: In humans, this has been tested primarily for the 5-HT1A receptor, where SSRI treatment for MDD indeed has been associated with a reduction of raphe 5-HT1A receptor binding, although this change did not correlate with treatment response (Sargent et al., 2000; Gray et al., 2013).